3048 companies

Aytu BioPharma

Market Cap: US$20.2m

A pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.

AYTU

US$2.25

7D

-4.3%

1Y

-5.9%

NovaBay Pharmaceuticals

Market Cap: US$21.7m

Does not have significant operations.

NBY

US$3.73

7D

109.6%

1Y

736.7%

Ardelyx

Market Cap: US$1.6b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARDX

US$6.52

7D

2.5%

1Y

16.4%

Viking Therapeutics

Market Cap: US$3.0b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

VKTX

US$26.98

7D

-0.3%

1Y

-50.2%

Evogene

Market Cap: ₪36.3m

Operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.

EVGN

₪4.05

7D

-4.3%

1Y

-64.0%

AcouSort

Market Cap: SEK 66.7m

A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.

ACOU

SEK 3.15

7D

-2.2%

1Y

-79.3%

Cannonau

Market Cap: US$48.4k

Engages in the provision of cannabidiol based products.

CNNC

US$0.0002

7D

100.0%

1Y

-90.9%

Eton Pharmaceuticals

Market Cap: US$479.2m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

ETON

US$17.67

7D

2.1%

1Y

285.0%

Innovotech

Market Cap: CA$10.5m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

IOT

CA$0.21

7D

-12.5%

1Y

61.5%

Kiora Pharmaceuticals

Market Cap: US$9.4m

A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.

KPRX

US$2.68

7D

-3.6%

1Y

-24.3%

Adagene

Market Cap: US$100.9m

A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.

ADAG

US$2.20

7D

3.3%

1Y

-15.7%

OnKure Therapeutics

Market Cap: US$36.4m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers.

OKUR

US$2.75

7D

0%

1Y

n/a

Lipigon Pharmaceuticals

Market Cap: SEK 104.5m

Develops drugs for lipid related diseases in Sweden.

LPGO

SEK 0.17

7D

-7.0%

1Y

-32.1%

Galmed Pharmaceuticals

Market Cap: US$7.0m

A biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases.

GLMD

US$1.36

7D

7.1%

1Y

-55.0%

Corvus Pharmaceuticals

Market Cap: US$427.0m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

CRVS

US$6.16

7D

7.3%

1Y

52.9%

Elicera Therapeutics

Market Cap: SEK 338.3m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

ELIC

SEK 6.97

7D

-1.4%

1Y

285.1%

ImmuCell

Market Cap: US$59.0m

An animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.

ICCC

US$6.33

7D

-1.1%

1Y

58.6%

CareDx

Market Cap: US$697.3m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

CDNA

US$13.82

7D

1.2%

1Y

-49.0%

ArriVent BioPharma

Market Cap: US$791.9m

A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

AVBP

US$20.19

7D

5.6%

1Y

-27.9%

High Tech Pharm

Market Cap: ₩136.0b

Researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide.

A106190

₩12,790.00

7D

7.5%

1Y

-6.1%

Cisen Pharmaceutical

Market Cap: CN¥11.4b

Research, develops, produces, and sells drug products in China and internationally.

603367

CN¥25.21

7D

-1.0%

1Y

103.8%

Vivo Bio Tech

Market Cap: ₹777.2m

Provides drug development and discovery services to pharmaceutical and biotech companies worldwide.

511509

₹36.43

7D

-1.0%

1Y

-2.5%

Whan In PharmLtd

Market Cap: ₩160.2b

Manufactures and sells various pharmaceuticals products in South Korea.

A016580

₩10,490.00

7D

-0.9%

1Y

-19.7%

Innovent Biologics

Market Cap: HK$176.6b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

1801

HK$103.10

7D

6.5%

1Y

138.9%

C&R Research

Market Cap: ₩56.6b

n/a

A359090

₩993.00

7D

-1.6%

1Y

-12.0%

Jiangsu Jibeier Pharmaceutical

Market Cap: CN¥8.0b

A pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs.

688566

CN¥40.23

7D

8.1%

1Y

104.3%

Shaanxi Panlong Pharmaceutical Group Limited By Share

Market Cap: CN¥3.1b

Researches and develops, produces, and sells Chinese patent medicines in China.

002864

CN¥29.44

7D

-0.9%

1Y

23.5%

AstraZeneca Pharma India

Market Cap: ₹227.2b

A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.

506820

₹9,088.15

7D

7.3%

1Y

31.7%

Innova Captab

Market Cap: ₹52.0b

An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.

INNOVACAP

₹908.90

7D

0.8%

1Y

20.9%

Ildong Holdings

Market Cap: ₩99.1b

Develops, manufactures, and supplies pharmaceutical products in South Korea and internationally.

A000230

₩8,780.00

7D

-4.8%

1Y

13.0%

Silco Pharmaceuticals

Market Cap: ৳1.7b

Engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally.

SILCOPHL

৳16.60

7D

1.2%

1Y

-12.2%

HitGen

Market Cap: CN¥10.8b

Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.

688222

CN¥27.06

7D

4.6%

1Y

210.3%

Sino Biopharmaceutical

Market Cap: HK$159.4b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

1177

HK$8.91

7D

9.9%

1Y

181.1%

OPC Pharmaceutical

Market Cap: ₫1.5t

Engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicines in Vietnam and internationally.

OPC

₫22,950.00

7D

-0.2%

1Y

-1.5%

Dynavax Technologies

Market Cap: US$1.2b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

DVAX

US$10.06

7D

-0.6%

1Y

-8.8%

May & Baker Nigeria

Market Cap: ₦31.1b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

MAYBAKER

₦18.05

7D

0%

1Y

157.9%

Page 18 of 85